Search results

Order by most recent / most popular / relevance

Results: 1-10 of 30

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

Morrison & Foerster LLP
-
Argentina, Brazil, Chile, China, Hong Kong, Japan, Malaysia, Mexico, Philippines, South Korea, Thailand, USA, Vietnam
-
June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation

A Japanese patent system which promotes industrial development: one patent attorney’s perspective

Shiga International Patent Office
-
Japan
-
May 8 2013

How the Japanese patent system should be reformed in order to encourage industrial development is a major issue in Japan. Currently, most technical

Joint infringement case of Intellectual Property High Court of Japan - INTERNET Number Corporation (plaintiff appellant) v. Netpia Inc. (defendant)

Shiga International Patent Office
-
Japan
-
April 22 2013

In the Akamai case, CAFC made a historical decision on August 31, 2012, in that a joint infringement via Internet was decided to constitute the

Overview of patent-statutory subject matter in biotechnology

CCPIT Patent & Trademark Law Office
-
China, European Union, Japan, USA
-
April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

Japan, S. Korea, and Germany lead in nanotech patenting for non-USA countries

Foley & Lardner LLP
-
Germany, Japan, South Korea, USA
-
May 4 2011

From the beginnings of the NNI, the "race" between the industrialized countries to develop nanotechnology was a focus point

Protection for medical-related inventions in Japan

Shiga International Patent Office
-
Japan
-
April 8 2013

Japan has the second largest medical market in the world. For instance, there has been active development in recent years concerning regenerative

Protective orders in patent infringement litigation in Japan

Shiga International Patent Office
-
Japan
-
March 5 2013

There are many patent infringement litigation cases in Japan in which protective orders are issued. However, it appears that there are few cases in

IP trends in iPS cell technology

Shiga International Patent Office
-
Japan
-
November 15 2012

The 2012 Nobel Prize in Physiology or Medicine was awarded to Sir John B. Gurdon, a professor at the University of Cambridge, and Dr. Shinya Yamanaka, Director of the Center for iPS Cell Research and Application (CiRA) at Kyoto University, for their discovery that “mature cells can be reprogrammed to a pluripotent stem cell state”

Recent trends concerning the judgment of inventive step in Japan

Shiga International Patent Office
-
Japan
-
March 18 2013

The patent grant ratio has been increasing year by year recently in Japan. For example, according to the Japanese Patent Office (JPO), the ratio went

next >

Search results

Dispelling the Myriad gene patent harmonization myth

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

A Japanese patent system which promotes industrial development: one patent attorney’s perspective

Joint infringement case of Intellectual Property High Court of Japan - INTERNET Number Corporation (plaintiff appellant) v. Netpia Inc. (defendant)

Overview of patent-statutory subject matter in biotechnology

Japan, S. Korea, and Germany lead in nanotech patenting for non-USA countries

Protection for medical-related inventions in Japan

Protective orders in patent infringement litigation in Japan

IP trends in iPS cell technology

Recent trends concerning the judgment of inventive step in Japan

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea